Ardelyx Inc
F:41X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ardelyx Inc
F:41X
|
US |
|
C
|
CVS Health Corp
DUS:CVS
|
US |
|
Agree Realty Corp
F:AGL
|
US |
|
D
|
Deutsche Boerse AG
DUS:DB1
|
DE |
|
Barratt Developments P L C
LSE:BDEV
|
UK |
|
A
|
Adevinta ASA
F:AD5B
|
NO |
|
T
|
TMX Group Ltd
F:9TX
|
CA |
|
F
|
Fluor Corp
XBER:FLU
|
US |
|
B
|
Bilfinger SE
DUS:GBF
|
DE |
|
T
|
Thermo Fisher Scientific Inc
F:TN8
|
US |
|
Woolworths Holdings Ltd
F:WN3
|
ZA |
|
T
|
Takkt AG
DUS:TTK
|
DE |
|
D
|
DaVita Inc
XMUN:TRL
|
US |
|
L
|
Live Nation Entertainment Inc
F:3LN
|
US |
|
I
|
Intuit Inc
XMUN:ITU
|
US |
|
MTU Aero Engines AG
F:MTX1
|
DE |
|
T
|
Tsingtao Brewery Co Ltd
XBER:TSI
|
CN |
|
Clariane SE
OTC:KRNMF
|
FR |
|
L
|
Longfor Group Holdings Ltd
XMUN:RLF
|
CN |
|
Vivoryon Therapeutics NV
F:05Y
|
DE |
|
P
|
Procter & Gamble Co
BMV:PG
|
US |
|
S
|
Sekisui House Ltd
XMUN:SPH1
|
JP |
Bankruptcy Probability
Ardelyx Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ardelyx Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Ardelyx Inc
NASDAQ:ARDX
|
1.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
356.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
57.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ardelyx Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ardelyx Inc has total debt of 203.5m USD. This includes both short-term (0 USD) and long-term (203.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
